22 April 2016 - A public submission process for the post-market reviews of medicines to treat patients with pulmonary arterial hypertension and the biological disease modifying anti-rheumatic drugs to treat patients with chronic plaque psoriasis will commence on 2 May 2016.

The public submission process will be open for two weeks and will close at 5 pm Monday, 16 May 2016.

For more details, go to: http://www.pbs.gov.au/info/reviews/post-market-review-pah